Skip to main content
Clinical Trials/NCT06390046
NCT06390046
Completed
Not Applicable

Comparison of Total Intravenous Anesthesia and Inhalational Anesthesia in Opioid-Free Anesthesia for Bariatric Surgery: A Randomized Controlled Trial

Jagiellonian University1 site in 1 country280 target enrollmentMarch 14, 2024

Overview

Phase
Not Applicable
Intervention
TIVA versus Inhalation
Conditions
Analgesics, Opioid
Sponsor
Jagiellonian University
Enrollment
280
Locations
1
Primary Endpoint
presence of PONV in postoperative period
Status
Completed
Last Updated
8 months ago

Overview

Brief Summary

Total intravenous general anesthesia and combined general anesthesia are recognized methods used during anesthesia. They allow you to effectively control pain and reduce the number of complications associated with taking large doses of opioid drugs. It should be emphasized that both methods of anesthesia are currently approved for use in routine anesthetic practice, and only the experience, knowledge and preferences of the anesthesiologist determine which technique will be used in a given patient. Both techniques are used in everyday anesthetic practice, but there is no conclusive scientific data confirming the superiority of either method in patients undergoing bariatric surgery, therefore currently only the individual experience, knowledge and preferences of the anesthesiologist determines which technique will be used in a given patient.

Detailed Description

Patients undergoing bariatric surgery were randomly divided into two groups: one under complete intravenous anesthesia (infusion of Propofol, Ketamine, Lignocaine and Dexmedetomidine) and the other group under combined general anesthesia (infusion of Ketamine, Lignocaine and Dexmedetomidine and inhalation of Sevoflurane). In the postoperative period, all patients will receive Oxycodone NCA or in the form of oral tablets \[naloxone (naloxone hydrochloride) + oxycodone (oxycodone hydrochloride)\] and coanalgesics in the form of Paracetamol, Dexac, and Metamizol. Both methods of anesthesia are commonly used and used during bariatric and other surgical procedures. It should be emphasized once again that the above-mentioned all drugs are approved for routine use during anesthesia of patients, including obese patients, and our intervention only involves the use of a specific regimen from among those routinely available. The choice of anesthesia method depends on the anesthesiologist. During the study, we want to randomize patients into two groups: one will be anesthetized using a completely intravenous method, the other will be anesthetized using an inhalation anesthetic. In the postoperative period, patients will have their pain level assessed using the NRS scale 1, 2, 6, 12 and 24 hours after the procedure. This study aimed to compare TIVA (propofol plus non-opioid adjuncts) with a sevoflurane-based anesthesia protocol, both incorporating OFA principles with lidocaine, ketamine, and dexmedetomidine infusions, in patients undergoing laparoscopic bariatric surgery. We hypothesized that both regimens would provide effective analgesia and recovery, with differences in recovery characteristics and postoperative nausea profiles. Moreover, we intended to evaluate whether a sevoflurane-based approach could match the clinical benefits of TIVA while aligning with current ecological and sustainability priorities in anesthesia.

Registry
clinicaltrials.gov
Start Date
March 14, 2024
End Date
December 31, 2024
Last Updated
8 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Jagiellonian University
Responsible Party
Principal Investigator
Principal Investigator

Tomasz Skladzien

PHD MD

Jagiellonian University

Eligibility Criteria

Inclusion Criteria

  • Patients over 18 years who underwent laparoscopic bariatric surgery

Exclusion Criteria

  • Patients with a history of allergic reactions to drugs Patients with a history of drug addiction Patients with chronic pain who require analgesics History of hospitalization for psychiatric disorders Preoperative pulse oximetry (SpO2) \< 95 % bradycardia (HR\<50bpm), hypotension, atrioventricular block, intraventricular or sinus block Blood clotting disorders Pregnant/lactating women Cognitive impairment Unable to read consent

Arms & Interventions

TIVA

total intravenously anesthetized (infusion of Propofol, Ketamine, Lignocaine and Dexmedetomidine)

Intervention: TIVA versus Inhalation

Inhalation agent

combined general anesthesia (infusion of Ketamine, Lignocaine and Dexmedetomidine and inhalation of Sevoflurane)

Intervention: TIVA versus Inhalation

Outcomes

Primary Outcomes

presence of PONV in postoperative period

Time Frame: 1 day

The incidence of postoperative nausea and vomiting (PONV) within the first 24 hours after surgery

Secondary Outcomes

  • Postoperative recovery parameters(1 day)
  • Opioid consumption(1 day)

Study Sites (1)

Loading locations...

Similar Trials